NO994135D0 - Kinoksalindioner - Google Patents
KinoksalindionerInfo
- Publication number
- NO994135D0 NO994135D0 NO994135A NO994135A NO994135D0 NO 994135 D0 NO994135 D0 NO 994135D0 NO 994135 A NO994135 A NO 994135A NO 994135 A NO994135 A NO 994135A NO 994135 D0 NO994135 D0 NO 994135D0
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- quinoxalinediones
- solvate
- compounds
- processes
- Prior art date
Links
- SEPKUNXLGWMPHL-UHFFFAOYSA-N quinoxaline-2,3-dione Chemical class C1=CC=CC2=NC(=O)C(=O)N=C21 SEPKUNXLGWMPHL-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Addiction (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Luminescent Compositions (AREA)
- Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP1997/000995 WO1997032873A1 (en) | 1996-03-09 | 1997-02-27 | Quinoxalinediones |
| GBGB9715783.8A GB9715783D0 (en) | 1997-02-27 | 1997-07-25 | Quinoxalinediones |
| PCT/EP1998/001275 WO1998038186A1 (en) | 1997-02-27 | 1998-02-24 | Quinoxalinediones |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO994135D0 true NO994135D0 (no) | 1999-08-26 |
| NO994135L NO994135L (no) | 1999-10-22 |
Family
ID=26070194
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO994135A NO994135L (no) | 1997-02-27 | 1999-08-26 | Kinoksalindioner |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0973766B1 (no) |
| JP (2) | JP3588363B2 (no) |
| CN (2) | CN1121403C (no) |
| AT (1) | ATE282608T1 (no) |
| BG (1) | BG103685A (no) |
| BR (1) | BR9808126A (no) |
| CA (1) | CA2281580C (no) |
| DE (1) | DE69827614T2 (no) |
| ES (1) | ES2230685T3 (no) |
| HR (1) | HRP980104A2 (no) |
| HU (1) | HUP0003612A3 (no) |
| NO (1) | NO994135L (no) |
| NZ (1) | NZ336842A (no) |
| SK (1) | SK113399A3 (no) |
| TR (1) | TR199902055T2 (no) |
| WO (1) | WO1998038186A1 (no) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9605027D0 (en) * | 1996-03-09 | 1996-05-08 | Pfizer Ltd | Quinoxalinediones |
| GB0310881D0 (en) * | 2003-05-12 | 2003-06-18 | Merck Sharp & Dohme | Pharmaceutical formulation |
| MY145368A (en) * | 2004-01-13 | 2012-01-31 | Nissan Chemical Ind Ltd | Aminoquinoxaline compounds and polyaminoquinoxaline compounds, and use thereof |
| CN1926647B (zh) | 2004-02-06 | 2010-04-14 | 国立大学法人山口大学 | 储能装置用电极及其制造方法 |
| JP2009539846A (ja) * | 2006-06-06 | 2009-11-19 | ブリストル−ミエルス スクイッブ カンパニー | Ｎ−［５−［［［５−（１，１−ジメチルエチル）−２−オキサゾリル］メチル］チオ］−２−チアゾリル］−４−ピペリジンカルボキサミドの結晶形 |
| CN104370834B (zh) | 2007-05-17 | 2017-04-19 | 株式会社半导体能源研究所 | 三唑衍生物 |
| DK2493871T3 (da) * | 2009-10-30 | 2014-11-10 | Prestwick Chemical Sas | Nye oximderivater samt deres anvendelse som allosteriske modulatorer af metabotropiske glutamatreceptorer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992007847A1 (fr) * | 1990-11-06 | 1992-05-14 | Yamanouchi Pharmaceutical Co., Ltd. | Derive de pyrazine fusionnee |
| DE4217952A1 (de) * | 1992-05-30 | 1993-12-02 | Basf Ag | Chinoxalin-2,3(1H,4H)-dione |
| GB9605027D0 (en) * | 1996-03-09 | 1996-05-08 | Pfizer Ltd | Quinoxalinediones |
-
1998
- 1998-02-24 NZ NZ336842A patent/NZ336842A/xx unknown
- 1998-02-24 AT AT98913660T patent/ATE282608T1/de not_active IP Right Cessation
- 1998-02-24 SK SK1133-99A patent/SK113399A3/sk unknown
- 1998-02-24 EP EP98913660A patent/EP0973766B1/en not_active Expired - Lifetime
- 1998-02-24 CA CA002281580A patent/CA2281580C/en not_active Expired - Fee Related
- 1998-02-24 WO PCT/EP1998/001275 patent/WO1998038186A1/en not_active Ceased
- 1998-02-24 TR TR1999/02055T patent/TR199902055T2/xx unknown
- 1998-02-24 CN CN98802879A patent/CN1121403C/zh not_active Expired - Fee Related
- 1998-02-24 HU HU0003612A patent/HUP0003612A3/hu unknown
- 1998-02-24 JP JP53732798A patent/JP3588363B2/ja not_active Expired - Fee Related
- 1998-02-24 BR BR9808126-8A patent/BR9808126A/pt not_active Application Discontinuation
- 1998-02-24 DE DE69827614T patent/DE69827614T2/de not_active Expired - Fee Related
- 1998-02-24 ES ES98913660T patent/ES2230685T3/es not_active Expired - Lifetime
- 1998-02-26 HR HR9715783.8A patent/HRP980104A2/hr not_active Application Discontinuation
-
1999
- 1999-08-24 BG BG103685A patent/BG103685A/bg unknown
- 1999-08-26 NO NO994135A patent/NO994135L/no unknown
-
2003
- 2003-03-20 CN CN03107362A patent/CN1443763A/zh active Pending
-
2004
- 2004-07-02 JP JP2004196277A patent/JP2004269547A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| SK113399A3 (en) | 2001-04-09 |
| DE69827614D1 (de) | 2004-12-23 |
| HUP0003612A2 (hu) | 2001-10-28 |
| CN1248971A (zh) | 2000-03-29 |
| HUP0003612A3 (en) | 2003-04-28 |
| DE69827614T2 (de) | 2005-11-10 |
| NZ336842A (en) | 2000-05-26 |
| CA2281580A1 (en) | 1998-09-03 |
| BR9808126A (pt) | 2000-03-08 |
| TR199902055T2 (xx) | 2000-07-21 |
| CN1443763A (zh) | 2003-09-24 |
| JP2000509730A (ja) | 2000-08-02 |
| ATE282608T1 (de) | 2004-12-15 |
| JP3588363B2 (ja) | 2004-11-10 |
| EP0973766A1 (en) | 2000-01-26 |
| WO1998038186A1 (en) | 1998-09-03 |
| CN1121403C (zh) | 2003-09-17 |
| EP0973766B1 (en) | 2004-11-17 |
| CA2281580C (en) | 2003-04-22 |
| BG103685A (bg) | 2000-06-30 |
| JP2004269547A (ja) | 2004-09-30 |
| HRP980104A2 (en) | 1999-02-28 |
| NO994135L (no) | 1999-10-22 |
| ES2230685T3 (es) | 2005-05-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| YU41199A (sh) | Hinoksalindioni | |
| MXPA02012033A (es) | Derivados de 2-aminocarbonil-9h-purina. | |
| ATE297203T1 (de) | Antithrombotische mitteln | |
| DE69831868D1 (en) | Antithrombosemittel | |
| BR0210078A (pt) | Composto, uso do mesmo, e, formulação farmacêutica | |
| TR199901191T2 (xx) | Benzamidoaldehitlerin sistein proteaz� inhibit�r� olarak kullan�m�. | |
| BR9303993A (pt) | Composto, processo para preparar o mesmo e composição farmacêutica | |
| IL142649A0 (en) | Azole derivatives | |
| EA199900373A2 (ru) | Фармацевтические композиции | |
| NO20006323D0 (no) | Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse | |
| DE69932173D1 (de) | Adenine-derivate | |
| AU2003228770A1 (en) | Substituted pyrazolopyrimidines | |
| MXPA04003886A (es) | Tiofen- y tiazolsulfonamidas como agentes antineoplasticos. | |
| MY124078A (en) | Eletriptan hydrobromide monohydrate | |
| DE69827614D1 (de) | Chinoxalindionen | |
| DE60201074D1 (en) | Pyrazolopyridinderivate | |
| WO2003080631A3 (en) | Plasma carboxypeptidase b inhibitors | |
| SE9904128D0 (sv) | Novel compounds | |
| MY129094A (en) | Condensed polycyclic compounds | |
| TW371661B (en) | Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides | |
| EA199900688A1 (ru) | Хиноксалиндионы | |
| YU82302A (sh) | Derivati 2-aminokarbonil-9h-purina | |
| BR9915898A (pt) | Compostos, composição farmacêutica, e, utilização de um composto | |
| AU1783700A (en) | 1,8-benzonaphthyridine derivatives | |
| TWI231815B (en) | Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents |